Your browser doesn't support javascript.
loading
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Wechsler, Michael E; Colice, Gene; Griffiths, Janet M; Almqvist, Gun; Skärby, Tor; Piechowiak, Teresa; Kaur, Primal; Bowen, Karin; Hellqvist, Åsa; Mo, May; Garcia Gil, Esther.
Afiliación
  • Wechsler ME; National Jewish Health, Denver, CO, USA. mikewechsler@gmail.com.
  • Colice G; Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Griffiths JM; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Almqvist G; Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Skärby T; Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Piechowiak T; Development Operations, BioPharmaceuticals R&D, AstraZeneca, Mississauga, ON, Canada.
  • Kaur P; Amgen, Thousand Oaks, CA, USA.
  • Bowen K; Biometrics, Late Respiratory & Immunology, BioPharmaceuticals R&D, Gaithersburg, MD, USA.
  • Hellqvist Å; Biometrics, Late Respiratory & Immunology, BioPharmaceuticals R&D, Gothenburg, Sweden.
  • Mo M; Amgen, Thousand Oaks, CA, USA.
  • Garcia Gil E; Global Medical Respiratory, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.
Respir Res ; 21(1): 264, 2020 Oct 13.
Article en En | MEDLINE | ID: mdl-33050928

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Corticoesteroides / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Asma / Corticoesteroides / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos